Axon Enterprise, Inc.
General ticker "AXON" information:
- Sector: Industrials
- Industry: Aerospace & Defense
- Capitalization: $48.3B (TTM average)
Axon Enterprise, Inc. does not follow the US Stock Market performance with the rate: -18.3%.
Estimated limits based on current volatility of 3.4%: low 501.80$, high 537.02$
Factors to consider:
- Company included in S&P500 list
- Company included in NASDAQ-100 index
- Total employees count: 4100 (-3.8%) as of 2024
- US accounted for 85.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on law enforcement, CED sales acceptance, New product risks, Rapid tech changes, Negative publicity
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [372.95$, 636.90$]
- 2026-12-31 to 2027-12-31 estimated range: [313.00$, 546.19$]
Financial Metrics affecting the AXON estimates:
- Negative: with PPE of 84.6 at the end of fiscal year the price was very high
- Positive: -5.34 < Operating profit margin, % of -2.18
- Positive: Interest expense per share per price, % of 0.20 <= 0.74
- Positive: -0.03 < Operating cash flow per share per price, % of 0.45
- Negative: Industry operating cash flow per share per price (median), % of 0.71 <= 5.50
- Positive: 42.57 < Shareholder equity ratio, % of 46.32 <= 64.23
- Positive: -3.72 < Return on assets ratio (scaled to [-100,100]) of 1.75
- Negative: Investing cash flow per share per price, % of -1.56 <= -0.60
Short-term AXON quotes
Long-term AXON plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,560.70MM | $2,082.53MM | $2,779.54MM |
| Operating Expenses | $1,401.25MM | $2,023.99MM | $2,841.61MM |
| Operating Income | $159.45MM | $58.54MM | $-62.08MM |
| Non-Operating Income | $-2.39MM | $322.96MM | $81.05MM |
| Interest Expense | $7.00MM | $7.10MM | $94.24MM |
| R&D Expense | $303.72MM | $441.59MM | $684.31MM |
| Income(Loss) | $157.06MM | $381.50MM | $18.97MM |
| Taxes | $-18.72MM | $4.47MM | $-105.68MM |
| Net Income(Loss)* | $175.78MM | $377.03MM | $124.66MM |
| Stockholders Equity | $1,615.77MM | $2,327.66MM | $3,242.66MM |
| Inventory | $269.86MM | $265.32MM | $341.81MM |
| Assets | $3,409.17MM | $4,474.59MM | $7,000.31MM |
| Operating Cash Flow | $189.26MM | $408.31MM | $211.34MM |
| Capital expenditure | $59.63MM | $78.78MM | $136.26MM |
| Investing Cash Flow | $12.48MM | $-490.57MM | $-724.93MM |
| Financing Cash Flow | $41.31MM | $-45.44MM | $1,252.46MM |
| Earnings Per Share** | $2.37 | $4.98 | $1.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.